Rectal Nonsteroidal Anti-inflammatory Drugs for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis: A Case Study in a Price-Escalation Era

Gastroenterology. 2022 Sep;163(3):543-546. doi: 10.1053/j.gastro.2022.05.026. Epub 2022 May 19.

Authors

Katherine McKee¹, Vikesh K Singh², Venkata S Akshintala³

Affiliations

¹ Department of Engineering, University of Maryland, College Park, Maryland.
² Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
³ Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.

PMID: 35598627
DOI: 10.1053/j.gastro.2022.05.026

No abstract available

MeSH terms

Administration, Rectal
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Cholangiopancreatography, Endoscopic Retrograde* / adverse effects
Humans
Pancreatitis* / diagnosis
Pancreatitis* / etiology
Pancreatitis* / prevention & control

Substances

Anti-Inflammatory Agents, Non-Steroidal